Anti-SSBP2 monoclonal antibody

Pre-made anti-SSBP2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SSBP2/SSBP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1821-Ab-1/ GM-Tg-hg-IP1821-Ab-2Anti-Human SSBP2 monoclonal antibodyHuman
GM-Tg-rg-IP1821-Ab-1/ GM-Tg-rg-IP1821-Ab-2Anti-Rat SSBP2 monoclonal antibodyRat
GM-Tg-mg-IP1821-Ab-1/ GM-Tg-mg-IP1821-Ab-2Anti-Mouse SSBP2 monoclonal antibodyMouse
GM-Tg-cynog-IP1821-Ab-1/ GM-Tg-cynog-IP1821-Ab-2Anti-Cynomolgus/ Rhesus macaque SSBP2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1821-Ab-1/ GM-Tg-felg-IP1821-Ab-2Anti-Feline SSBP2 monoclonal antibodyFeline
GM-Tg-cang-IP1821-Ab-1/ GM-Tg-cang-IP1821-Ab-2Anti-Canine SSBP2 monoclonal antibodyCanine
GM-Tg-bovg-IP1821-Ab-1/ GM-Tg-bovg-IP1821-Ab-2Anti-Bovine SSBP2 monoclonal antibodyBovine
GM-Tg-equg-IP1821-Ab-1/ GM-Tg-equg-IP1821-Ab-2Anti-Equine SSBP2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1821-Ab-1/ GM-Tg-hg-IP1821-Ab-2; GM-Tg-rg-IP1821-Ab-1/ GM-Tg-rg-IP1821-Ab-2;
GM-Tg-mg-IP1821-Ab-1/ GM-Tg-mg-IP1821-Ab-2; GM-Tg-cynog-IP1821-Ab-1/ GM-Tg-cynog-IP1821-Ab-2;
GM-Tg-felg-IP1821-Ab-1/ GM-Tg-felg-IP1821-Ab-2; GM-Tg-cang-IP1821-Ab-1/ GM-Tg-cang-IP1821-Ab-2;
GM-Tg-bovg-IP1821-Ab-1/ GM-Tg-bovg-IP1821-Ab-2; GM-Tg-equg-IP1821-Ab-1/ GM-Tg-equg-IP1821-Ab-2
Products NameAnti-SSBP2 monoclonal antibody
Formatmab
Target NameSSBP2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SSBP2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1821-Ag-1Recombinant multi-species SSBP2/ HSPC116/ SOSS-B2 protein


    Target information

    Target IDGM-IP1821
    Target NameSSBP2
    Gene ID23635,66970,361877,711752,479160,101088719,616564,100073250
    Gene Symbol and Synonyms1500004K09Rik,2310079I02Rik,9330163K02Rik,A830008M03Rik,HSPC116,RGD1562968,SOSS-B2,SSBP2,SSDP2
    Uniprot AccessionP81877
    Uniprot Entry NameSSBP2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000145687
    Target ClassificationN/A

    The target: SSBP2, gene name: SSBP2, also named as HSPC116, SOSS-B2. This gene encodes a subunit of a protein complex that interacts with single-stranded DNA and is involved in the DNA damage response and maintenance of genome stability. The encoded protein may also play a role in telomere repair. A variant of this gene may be associated with survival in human glioblastoma patients. [provided by RefSeq, Sep 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.